MediciNova
MNOV
47 hedge funds and large institutions have $75.4M invested in MediciNova in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 3 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 13
0% more funds holding
Funds holding: 47 → 47 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.3% less ownership
Funds ownership: 21.89% → 21.58% (-0.3%)
6% less capital invested
Capital invested by funds: $79.9M → $75.4M (-$4.58M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$415K |
| 2 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
+$325K |
| 3 |
D.E. Shaw & Co
New York
|
+$312K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$137K |
| 5 |
Squarepoint
New York
|
+$122K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$915K |
| 2 |
Morgan Stanley
New York
|
-$660K |
| 3 |
Goldman Sachs
New York
|
-$405K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$185K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$117K |
MNOV Hedge Fund Activity: Q1 2019 in Review
47 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2019, worth a combined $75.4M — down 5.7% from $79.9M a quarter earlier.
Fund positioning in MNOV was balanced in Q1 2019: 3 funds opened new positions, 3 closed out, 18 added to existing stakes and 13 trimmed.
The largest buyer was Vanguard Group, adding an estimated $415K. The largest seller was BlackRock, cutting an estimated $915K.
- 47 institutional investors held MediciNova (MNOV) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $75.4M of MediciNova stock for Q1 2019, down 5.7% quarter-over-quarter.
- 3 funds opened new MediciNova positions in Q1 2019 and 3 closed out, a net change of 0 holders.
- The largest MediciNova buyer in Q1 2019 was Vanguard Group, an estimated $415K added.
- The largest MediciNova seller in Q1 2019 was BlackRock, an estimated $915K sold.
Based on aggregated 13F filings for Q1 2019.